Skip to main content

Query Privacy in ChEMBL


We have been asked several times for all the user-generated queries of ChEMBL - i.e. the structures sketched in to the interface that are then searched against the database. We will not (and in fact, physically can't) share these. Sorry. It is against both our institutional privacy policy, and standard Terms of Use, and also we've engineered the app to avoid us 'storing' any of this information where at all possible (e.g. in avoiding /tmp type fluff, minimizing residency time in caches, etc.).

There are clearly some advantages in pooling or analysing website search data - it highlights interesting trends, something becoming more interesting to a user community can spot emerging events, etc. It can alert to flu outbreaks (there was a Science paper from google on this, don't have the reference handy though - you may be able to find it with google though.....). There is a huge interest in many sites that I use in tracking and analysing query terms and usage patterns, and in some contexts this is just the thing to do - like when ebay teases me (and surely of all the tortured obsessive souls on the planet, it is just me and me alone) with a rare phosphor or perforation machin variant I don't have.

The types of query that people perform can clearly also be used to develop ways of improving a website, or specifically the performance of search queries - and for algorithm development this information can be like gold-dust. There are now many chemical fingerprint systems available, and adapting the features/structures of these to typical user queries is really valuable in their development.

There are essentially two distinct aspects to user's expectations/rights of privacy when using a website like ChEMBL.

  • There is a personal privacy issue - 'why is John Overington interested in compounds for the treatment of obesity?'. This is an primarily an embarrassment sort of thing ('hey, is this guy a bit chubby?'), or maybe a commercially sensitive thing ('he's interested in obesity stuff; heh, let's raise the price for him', or 'let's show him some adverts for chips', or 'let's contact his rival and let them know he's interested in his weight'). These latter things are behind the feature where you first search for a flight and the price is great, then the next time you look, it's gone up - allegedly.
  • There's a more fundamental IP issue though -  The simple disclosure of a search term can be commercially damaging, and potentially stop the development of life-saving therapies. The simplest case is chemical structure and drug patents. The most important patent claim in drug discovery is to have composition of matter (and don't get all hissy over pharma misusing the patent system, since patents are absolutely essential for the development of new medicines, the treatment of disease, improvement of food supplies, for funding future R&D, for a source of employment, license revenues to Universities, and taxation revenues, etc). This composition of matter is a claim of a novel chemical structure, that no-one has disclosed before, and it is useful for something. If the structure is not novel, then the patent can be readily invalidated.
Hopefully, you'll understand our reasons for maintaining both user and query privacy.

For an extra clear clarification - we do not, and cannot examine queries of users ourselves within the development team here at the EBI. In case you read the above text as sharing stuff solely with third parties.

Your use of ChEMBL is private, and always will be.


Comments

Bio to Chem said…
John, in regard to your second point there is (unless anyone knows otherwise) no patent case law precedent for a successful composition of matter opposition or invalidation based on the interception of chemical (or sequence for that matter) database queries. Strictly speaking the issue is the public exposure thereof in silico. Ipso facto I'm not sure your (or anyone els's) server cache would count as this in court (hacking in would be criminal interception). Until such time as a test case is prosecuted successful the risk remains close to zero, compared to, say, putting your lead structure on a poster.
jpo said…
You are right. There are some legal defences for 'accidental' disclosure, and also for malicious interception sort of thing. But these seem to go back in spirit to the olden days of real physical post and not electronic transmission.

But I think you misread the post - or a lot more likely I wasn't clear.

The point I was making that you can lose novelty by 'publishing' the query list. The sort of thing I mean is sharing the query list with 'the public', making the query list downloadable, opening up a searchable database of the queries, etc.

Popular posts from this blog

SureChEMBL Available Now

Followers of the ChEMBL group's activities and this blog will be aware of our involvement in the migration of the previously commercially available SureChem chemistry patent system, to a new, free-for-all system, known as SureChEMBL. Today we are very pleased to announce that the migration process is complete and the SureChEMBL website is now online. SureChEMBL provides the research community with the ability to search the patent literature using Lucene-based keyword queries and, much more importantly, chemistry-based queries. If you are not familiar with SureChEMBL, we recommend you review the content of these earlier blogposts here and here . SureChEMBL is a live system, which is continuously extracting chemical entities from the patent literature. The time it takes for a new chemical in the patent literature to become searchable in the SureChEMBL system is 1-2 days (WO patents can sometimes take a bit longer due to an additional reprocessing step). At time of writi

New SureChEMBL announcement

(Generated with DALL-E 3 ∙ 30 October 2023 at 1:48 pm) We have some very exciting news to report: the new SureChEMBL is now available! Hooray! What is SureChEMBL, you may ask. Good question! In our portfolio of chemical biology services, alongside our established database of bioactivity data for drug-like molecules ChEMBL , our dictionary of annotated small molecule entities ChEBI , and our compound cross-referencing system UniChem , we also deliver a database of annotated patents! Almost 10 years ago , EMBL-EBI acquired the SureChem system of chemically annotated patents and made this freely accessible in the public domain as SureChEMBL. Since then, our team has continued to maintain and deliver SureChEMBL. However, this has become increasingly challenging due to the complexities of the underlying codebase. We were awarded a Wellcome Trust grant in 2021 to completely overhaul SureChEMBL, with a new UI, backend infrastructure, and new f

ChEMBL & SureChEMBL anniversary symposium

  In 2024 we celebrate the 15th anniversary of the first public release of the ChEMBL database as well as the 10th anniversary of SureChEMBL. To recognise this important landmark we are organising a two-day symposium to celebrate the work achieved by ChEMBL and SureChEMBL, and look forward to its future.   Save the date for the ChEMBL 15 Year Symposium October 1-2, 2024     Day one will consist of four workshops, a basic ChEMBL drug design workshop; an advanced ChEMBL workshop (EUbOPEN community workshop); a ChEMBL data deposition workshop; and a SureChEMBL workshop. Day two will consist of a series of talks from invited speakers, a few poster flash talks, a local nature walk, as well as celebratory cake. During the breaks, the poster session will be a great opportunity to catch up with other users and collaborators of the ChEMBL resources and chat to colleagues, co-workers and others to find out more about how the database is being used. Lunch and refreshments will be pro

ChEMBL 34 is out!

We are delighted to announce the release of ChEMBL 34, which includes a full update to drug and clinical candidate drug data. This version of the database, prepared on 28/03/2024 contains:         2,431,025 compounds (of which 2,409,270 have mol files)         3,106,257 compound records (non-unique compounds)         20,772,701 activities         1,644,390 assays         15,598 targets         89,892 documents Data can be downloaded from the ChEMBL FTP site:  https://ftp.ebi.ac.uk/pub/databases/chembl/ChEMBLdb/releases/chembl_34/ Please see ChEMBL_34 release notes for full details of all changes in this release:  https://ftp.ebi.ac.uk/pub/databases/chembl/ChEMBLdb/releases/chembl_34/chembl_34_release_notes.txt New Data Sources European Medicines Agency (src_id = 66): European Medicines Agency's data correspond to EMA drugs prior to 20 January 2023 (excluding vaccines). 71 out of the 882 newly added EMA drugs are only authorised by EMA, rather than from other regulatory bodies e.g.

RDKit, C++ and Jupyter Notebook

Fancy playing with RDKit C++ API without needing to set up a C++ project and compile it? But wait... isn't C++ a compiled programming language? How this can be even possible? Thanks to Cling (CERN's C++ interpreter) and xeus-cling jupyter kernel is possible to use C++ as an intepreted language inside a jupyter notebook! We prepared a simple notebook showing few examples of RDKit functionalities and a docker image in case you want to run it. With the single requirement of docker being installed in your computer you'll be able to easily run the examples following the three steps below: docker pull eloyfelix/rdkit_jupyter_cling docker run -d -p 9999:9999 eloyfelix/rdkit_jupyter_cling open  http://localhost:9999/notebooks/rdkit_cling.ipynb  in a browser